EndoGastric Solutions Says 3 Papers at ACG 2018 Support TIF 2.0 Procedure for GERD

EndoGastric® Solutions tells us about three supportive posters at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting and Postgraduate Course.

Background

The Transoral Incisionless Fundoplication (TIF®) procedure for reflux is a minimally invasive endoscopic treatment, performed without the need for external incisions through the skin. The TIF 2.0 procedure offers patients who require an anatomical repair an effective treatment option to correct the underlying cause of GERD. Clinical studies suggest most patients stop using daily medications to control their symptoms and had their esophageal inflammation (esophagitis) eliminated up to five years after the TIF procedure.

The ACG 2018 annual meeting was held October 5 – 10 in Philadelphia, PA. Three posters at the event highlighted the safety and efficacy of the TIF 2.0 procedure for the treatment of gastroesophageal reflux disease (GERD). The TIF 2.0 procedure is a minimally invasive and endoscopic intervention that enables anatomical correction of the gastric valve without incisions or attendant complications associated with laparoscopic surgical fundoplication.

Clinician comments

Amit Sohagia, MD, a gastroenterologist at Easton Hospital, received the ACG’s Outstanding Poster Presenter Award for an abstract titled “Transoral Incisionless Fundoplication: Effectiveness in Improving Typical and Atypical Symptoms of Gastroesophageal Reflux Disease Incompletely Controlled with Medical Therapy.”

“With the prevalence of GERD increasing worldwide, a growing number of patients are living with reflux symptoms that reduce their quality of life and increase their risk of cancer,” said Dr. Sohagia. “Patients refractory to medical therapy may benefit from surgical intervention, but traditional invasive procedures are associated with a variety of adverse events. The results of our study add to the robust foundation of data demonstrating that the TIF procedure improves quality of life in patients by effectively addressing both typical and atypical GERD symptoms.”

“The results of our study add to the robust foundation of data demonstrating that the TIF procedure improves quality of life in patients by effectively addressing both typical and atypical GERD symptoms.” Amit Sohagia, MD, Easton Hospital

Company comments

“The data presented at ACG 2018 continues to demonstrate that TIF 2.0 procedure is a safe and effective approach to treating GERD in a variety of patient populations and can be performed in the operating room or the endoscopy suite,” said Skip Baldino, President and CEO of EndoGastric Solutions. “These results highlight the clinical benefits that the TIF 2.0 procedure provides to patients and the workflow flexibility that it affords physicians and care centers. We congratulate Dr. Sohagia on receiving the Outstanding Poster Presenter Award, and for his continued efforts to help the GERD patients he serves.”

The two other posters presented at ACG 2018 were:

“Efficacy and Safety of Trans-Oral Incisionless Fundoplication Performed by Gastroenterologists,” which demonstrated that gastroenterologists trained in TIF procedure can safely perform the procedure in the endoscopy suite. This may save time and healthcare resources by reducing operating room (OR) use. The study also found that TIF procedure performed by gastroenterologists effectively improved HRQL in patients with symptomatic GERD. Presented by Ali Raza, MD1, Marc Catalano, MD1, Erik F. Rahimi, MD1, Hani A Zamil, MD2, Bijun S. Kannadath, MBBS, MS3, Julie Guider, MD1, Reena V. Chokshi, MD4, Brooks D. Cash, MD, FACG1, Todd Wilson, MD1, Erik Wilson, MD1, Nirav Thosani, MD2;1University of Texas Health Science Center at Houston, Houston, TX; 2University of Texas Health Science Center at Houston / McGovern Medical School, Houston, TX; 3University of Arizona College of Medicine, Phoenix, AZ; 4UT Health – McGovern Medical School, Houston, TX.

“Transoral Incisionless Fundoplication in a Patient with Dysphagia from Peptic Stricture,” which showed that TIF procedure can be used to reduce esophageal acid exposure and prevent stricture recurrence in a patient with dysphagia due to recurrent peptic stricture. Presented by Zain Iqbal Memon, DO, David Dicaprio, DO, Patrick Okolo, MD; Northwell Health Lenox Hill Hospital, New York, NY.

 

Source: Business Wire

Share your thoughts

Your email address will not be published. Required fields are marked *